Cargando…
Gut Microbiota and Metabolite Changes in Patients With Ulcerative Colitis and Clostridioides difficile Infection
BACKGROUND: Patients with ulcerative colitis (UC) are at an increased risk of developing Clostridioides difficile infection (CDI), which in turn leads to poor outcomes. The gut microbial structure and metabolites in patients with UC and CDI have been scarcely studied. We hypothesized that CDI change...
Autores principales: | Wan, Jian, Zhang, Yujie, He, Wenfang, Tian, Zuhong, Lin, Junchao, Liu, Zhenzhen, Li, Yani, Chen, Min, Han, Shuang, Liang, Jie, Shi, Yongquan, Wang, Xuan, Zhou, Lei, Cao, Ying, Liu, Jiayun, Wu, Kaichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231613/ https://www.ncbi.nlm.nih.gov/pubmed/35756051 http://dx.doi.org/10.3389/fmicb.2022.802823 |
Ejemplares similares
-
Faecal microbiota transplantation as a non-standard therapy for the treatment of Clostridioides difficile in an ulcerative colitis patient
por: Pendrasik, Karolina, et al.
Publicado: (2022) -
Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Liu, Xiaolei, et al.
Publicado: (2021) -
Concomitant Clostridioides difficile and Edwardsiella tarda Infection in a Patient with Ulcerative Colitis
por: Fukuda, Hiromu, et al.
Publicado: (2022) -
Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022) -
Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation
por: Kang, Seok Hyung, et al.
Publicado: (2023)